News
Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced the appointment of Dr. Nicholas Botwood BSc (Hons), MBBS, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback